DataExpo GAKG DeepReport Navigation

Copyright©2015-2024 Acemap, Inc. Shanghai Jiao Tong University. All rights reserved.

沪ICP备18028330号

AB

A Boissonnas

Hôpitaux Universitaires Paris-Ouest

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

B Christoforov

Institut Pasteur

Isabelle Varescon

Laboratoire de Psychopathologie et Processus de Santé

G. Vidal-Trécan

Université Paris Cité

C Laroche

Centre Hospitalier Universitaire Sainte-Justine

P Khalifa

Delta University for Science and Technology

D. Séréni

Assistance Publique – Hôpitaux de Paris

Didier Sicard

Université Paris Cité

Joël Coste

Santé Publique France

Crémer Ga

Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale

Cremer Ga

Bio-Rad (France)

Cooperative Institutions

Assistance Publique – Hôpitaux de Paris

Hôpital Cochin

Inserm

Université Paris Cité

Sorbonne Université

Centre National de la Recherche Scientifique

Délégation Paris 6

Délégation Paris 5

Hôpital Paul-Brousse

Université Paris-Saclay

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Observatoire national des Traitements visant à l'Abstinence d'agonistes opiacés chez les patients Dépendants (OTAD)

Jean Vignau A Boissonnas Jean Tignol Yannick Millot Alain Mucchielli

Cite

Citations (0)

[Silicosis due to drug addiction to a scouring powder].

Philippe Casassus A Boissonnas Luschevici Laroche Cl F Basset

Silicosis

Cite

Citations (0)

[Recurrent bilateral pleurisy in an 80-year-old man].

I Herry F Schaison Analía Martín B Christoforov A Boissonnas

Pleurisy

Cite

Citations (0)

[How to treat a patient with AIDS and drug dependence unwilling and/or unable to withdraw? Give substitution drugs at the hospital? Should substitution be continued after discharge? Is substitution a useful adjuvant to programs designed to prevent opportunistic diseases?] opportunisticinfections?].

Substitution (logic)

Substitution therapy

Cite

Citations (0)

[Absence of hyperfixation in bone scintigraphy during the initial days of typhoid osteitis].

E. Bruckert D. Séréni Bruno Richard Robert Fournier C Bricaire

Bone scintigraphy

Cite

Citations (1)

Points: Multiple endocrine neoplasia associated with von Recklinghausen's disease

A Boissonnas P Khalifa O Meyniard

10.1136/bmj.287.6408.1885-d

Cite

Citations (0)

P8-11 Analyse de comportements à risque pour la décision en santé publique : une enquête sur le mésusage de buprénorphine haut-dosage chez les usagers de drogues injectables

Revue d Épidémiologie et de Santé Publique (2004)

P. Plauzolles Isabelle Varescon Thierry Blanchon N. Nabet A Boissonnas

10.1016/s0398-7620(04)99307-8

Cite

Citations (1)

EDP Sciences eBooks (2004)

A Boissonnas G Vidal-Trécam Joël Coste Isabelle Varescon J Reboul-

10.1051/978-2-84254-208-5.fm

Cite

Citations (0)

[Attacks of gout and thromboembolic disease: role of heparin therapy].

P Khalifa D. Séréni A Boissonnas Crémer Ga C Laroche

The authors report 4 cases of acute gout in the lower limb occurring soon after starting heparin therapy for venous thromboembolic disease. As none of the usual factors which induce gout were present, the possible roles of the venous thrombosis and the heparin therapy were examined. Intra-articular thermic and acid-base changes secondary to the thrombosis could have explained the site of the attacks of gout in 3 of our 4 patients; the fourth patient had normal phlebography; the relationship between the attack and the start of heparin therapy suggested that the heparin may have induced the gout, possibly by an interaction with the synovial proteoglycans leading to the precipitation of urate crystals in the joint. In the absence of references in the literature, these hypotheses need further confirmation.

Thromboembolic disease

Arthropathy

Joint disease

Cite

Citations (5)

HCV status knowledge and risk behaviours amongst intravenous drug users.

European Journal of Epidemiology (2000)

G. Vidal-Trécan Joël Coste Isabelle Varescon B Christoforov A Boissonnas

Hepatitis C

Intravenous drug

10.1023/a:1007622831518

Cite

Citations (38)

More pages